These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15042552

  • 21. Pelvic insufficiency fracture related to autosomal dominant polycystic kidney disease.
    Ubara Y, Higa Y, Tagami T, Suwabe T, Nomura K, Kadoguchi K, Hoshino J, Sawa N, Katori H, Takemoto F, Kitajima I, Hara S, Takaichi K.
    Am J Kidney Dis; 2005 Dec; 46(6):e103-11. PubMed ID: 16310561
    [Abstract] [Full Text] [Related]

  • 22. Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence.
    Suwabe T, Oguro M, Ubara Y, Ikuma D, Mizuno H, Hayami N, Yamanouchi M, Sawa N.
    Intern Med; 2021 Dec; 60(20):3261-3265. PubMed ID: 34657906
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Transcatheter arterial embolization using ethanol in a dialysis patient for contracting enlarged polycystic kidneys.
    Rim H, Jung GS, Jung YS.
    Korean J Radiol; 2010 Dec; 11(5):574-8. PubMed ID: 20808704
    [Abstract] [Full Text] [Related]

  • 26. Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease.
    Mudge DW, Taylor J, Bannister KM.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2566-8. PubMed ID: 16141463
    [No Abstract] [Full Text] [Related]

  • 27. [Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy].
    Munemura C, Noguchi K, Yamamoto S, Murawaki Y, Uemasu J, Godai K.
    Nihon Jinzo Gakkai Shi; 2005 Nov; 47(4):458-62. PubMed ID: 15971889
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transcatheter arterial embolization with absolute ethanol injection for enlarged polycystic kidneys after failed metallic coil embolization.
    Sakuhara Y, Kato F, Abo D, Hasegawa Y, Shimizu T, Terae S, Shirato H.
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):267-71. PubMed ID: 18341960
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver Disease.
    Mizuta M, Sekine A, Suwabe T, Hoshino J, Yamanouchi M, Mizuno H, Ikuma D, Hasegawa E, Oba Y, Kono K, Kinowaki K, Ohashi K, Sawa N, Ubara Y.
    Intern Med; 2024 Nov 01; 63(21):2965-2970. PubMed ID: 38296484
    [Abstract] [Full Text] [Related]

  • 32. Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease.
    Misra A, Loyalka P, Alva F.
    South Med J; 1999 Jun 01; 92(6):626-7. PubMed ID: 10372860
    [Abstract] [Full Text] [Related]

  • 33. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S, Suzuki Y, Yoshimoto K, Nakamura Y, Munakata A.
    Nihon Jinzo Gakkai Shi; 1996 Jun 01; 38(6):278-84. PubMed ID: 8752971
    [Abstract] [Full Text] [Related]

  • 34. Ascites in a polycystic patient.
    Chauveau D, Grünfeld JP, Durand F, Belghiti J.
    Nephrol Dial Transplant; 1997 Jan 01; 12(1):228-30. PubMed ID: 9027810
    [No Abstract] [Full Text] [Related]

  • 35. Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.
    Sumida K, Hoshino J, Suwabe T, Kasai T, Hayami N, Mise K, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Narui K, Takaichi K, Ubara Y.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):949-56. PubMed ID: 25825485
    [Abstract] [Full Text] [Related]

  • 36. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.
    Uddin W, Ramage JK, Portmann B, Wilson P, Benjamin I, Tan KC, Williams R.
    Gut; 1995 Jan 05; 36(1):142-5. PubMed ID: 7890219
    [Abstract] [Full Text] [Related]

  • 37. Treatment of polycystic liver disease. Update on the management.
    Aussilhou B, Dokmak S, Dondero F, Joly D, Durand F, Soubrane O, Belghiti J.
    J Visc Surg; 2018 Dec 05; 155(6):471-481. PubMed ID: 30145049
    [Abstract] [Full Text] [Related]

  • 38. Comparison of volume-reductive therapies for massive polycystic liver disease in autosomal dominant polycystic kidney disease.
    Yang J, Ryu H, Han M, Kim H, Hwang YH, Chung JW, Yi NJ, Lee KW, Suh KS, Ahn C.
    Hepatol Res; 2016 Feb 05; 46(2):183-91. PubMed ID: 26190457
    [Abstract] [Full Text] [Related]

  • 39. Advances in management of polycystic liver disease.
    Everson GT, Helmke SM, Doctor B.
    Expert Rev Gastroenterol Hepatol; 2008 Aug 05; 2(4):563-76. PubMed ID: 19072404
    [Abstract] [Full Text] [Related]

  • 40. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ, Andronikou S, Kilborn T, Kaplan BS, Darge K.
    Pediatr Radiol; 2015 Mar 05; 45(3):386-95. PubMed ID: 25355409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.